ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies

Assunta Venuti, Claudia Pastori, Gabriel Siracusano, Agostino Riva, Maria Teresa Sciortino, Lucia Lopalco

Research output: Contribution to journalArticle

Abstract

Natural human Abs, recognizing an epitope within the first extramembrane loop of CCR5 (the main HIV coreceptor), induce a longlasting internalization (48 h) of the protein, whereas all known CCR5 modulating molecules show a short-term kinetics (60-90 min). Despite extensive studies on the regulation of CCR5 signaling cascades, which are the effect of concomitant CCR5 internalization by exogenous stimuli such as Abs, downstream signaling continues to be poorly understood. In this article, we report a hitherto unrecognized mechanism of CCR5 modulation mediated by G protein-dependent ERK1 activity. We further demonstrate that ERK1 is localized mainly in the cytoplasmic compartment and that it interacts directly with the CCR5 protein, thus provoking possible CCR5 degradation with a subsequent de novo synthesis, and that re-expression of CCR5 on the cell membrane required several days. In contrast, the RANTES treatment induces a recovery of the receptor on the cell membrane in short-term kinetics without the involvement of de novo protein synthesis. The said new pathway could be relevant not only to better understand the molecular basis of all pathologic conditions in which CCR5 is involved but also to generate new tools to block viral infections, such as the use of recombinant Abs.

Original languageEnglish
Pages (from-to)3045-3057
Number of pages13
JournalJournal of Immunology
Volume195
Issue number7
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Antibodies
Cell Membrane
Chemokine CCL5
Proteins
Virus Diseases
GTP-Binding Proteins
Epitopes
HIV

ASJC Scopus subject areas

  • Immunology
  • Medicine(all)

Cite this

ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies. / Venuti, Assunta; Pastori, Claudia; Siracusano, Gabriel; Riva, Agostino; Sciortino, Maria Teresa; Lopalco, Lucia.

In: Journal of Immunology, Vol. 195, No. 7, 01.10.2015, p. 3045-3057.

Research output: Contribution to journalArticle

Venuti, Assunta ; Pastori, Claudia ; Siracusano, Gabriel ; Riva, Agostino ; Sciortino, Maria Teresa ; Lopalco, Lucia. / ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies. In: Journal of Immunology. 2015 ; Vol. 195, No. 7. pp. 3045-3057.
@article{c28b3d7334994bfb8ab99fb8f48bca60,
title = "ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies",
abstract = "Natural human Abs, recognizing an epitope within the first extramembrane loop of CCR5 (the main HIV coreceptor), induce a longlasting internalization (48 h) of the protein, whereas all known CCR5 modulating molecules show a short-term kinetics (60-90 min). Despite extensive studies on the regulation of CCR5 signaling cascades, which are the effect of concomitant CCR5 internalization by exogenous stimuli such as Abs, downstream signaling continues to be poorly understood. In this article, we report a hitherto unrecognized mechanism of CCR5 modulation mediated by G protein-dependent ERK1 activity. We further demonstrate that ERK1 is localized mainly in the cytoplasmic compartment and that it interacts directly with the CCR5 protein, thus provoking possible CCR5 degradation with a subsequent de novo synthesis, and that re-expression of CCR5 on the cell membrane required several days. In contrast, the RANTES treatment induces a recovery of the receptor on the cell membrane in short-term kinetics without the involvement of de novo protein synthesis. The said new pathway could be relevant not only to better understand the molecular basis of all pathologic conditions in which CCR5 is involved but also to generate new tools to block viral infections, such as the use of recombinant Abs.",
author = "Assunta Venuti and Claudia Pastori and Gabriel Siracusano and Agostino Riva and Sciortino, {Maria Teresa} and Lucia Lopalco",
year = "2015",
month = "10",
day = "1",
doi = "10.4049/jimmunol.1500708",
language = "English",
volume = "195",
pages = "3045--3057",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "7",

}

TY - JOUR

T1 - ERK1-based pathway as a new selective mechanism to modulate CCR5 with natural antibodies

AU - Venuti, Assunta

AU - Pastori, Claudia

AU - Siracusano, Gabriel

AU - Riva, Agostino

AU - Sciortino, Maria Teresa

AU - Lopalco, Lucia

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Natural human Abs, recognizing an epitope within the first extramembrane loop of CCR5 (the main HIV coreceptor), induce a longlasting internalization (48 h) of the protein, whereas all known CCR5 modulating molecules show a short-term kinetics (60-90 min). Despite extensive studies on the regulation of CCR5 signaling cascades, which are the effect of concomitant CCR5 internalization by exogenous stimuli such as Abs, downstream signaling continues to be poorly understood. In this article, we report a hitherto unrecognized mechanism of CCR5 modulation mediated by G protein-dependent ERK1 activity. We further demonstrate that ERK1 is localized mainly in the cytoplasmic compartment and that it interacts directly with the CCR5 protein, thus provoking possible CCR5 degradation with a subsequent de novo synthesis, and that re-expression of CCR5 on the cell membrane required several days. In contrast, the RANTES treatment induces a recovery of the receptor on the cell membrane in short-term kinetics without the involvement of de novo protein synthesis. The said new pathway could be relevant not only to better understand the molecular basis of all pathologic conditions in which CCR5 is involved but also to generate new tools to block viral infections, such as the use of recombinant Abs.

AB - Natural human Abs, recognizing an epitope within the first extramembrane loop of CCR5 (the main HIV coreceptor), induce a longlasting internalization (48 h) of the protein, whereas all known CCR5 modulating molecules show a short-term kinetics (60-90 min). Despite extensive studies on the regulation of CCR5 signaling cascades, which are the effect of concomitant CCR5 internalization by exogenous stimuli such as Abs, downstream signaling continues to be poorly understood. In this article, we report a hitherto unrecognized mechanism of CCR5 modulation mediated by G protein-dependent ERK1 activity. We further demonstrate that ERK1 is localized mainly in the cytoplasmic compartment and that it interacts directly with the CCR5 protein, thus provoking possible CCR5 degradation with a subsequent de novo synthesis, and that re-expression of CCR5 on the cell membrane required several days. In contrast, the RANTES treatment induces a recovery of the receptor on the cell membrane in short-term kinetics without the involvement of de novo protein synthesis. The said new pathway could be relevant not only to better understand the molecular basis of all pathologic conditions in which CCR5 is involved but also to generate new tools to block viral infections, such as the use of recombinant Abs.

UR - http://www.scopus.com/inward/record.url?scp=84942475184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942475184&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1500708

DO - 10.4049/jimmunol.1500708

M3 - Article

C2 - 26324779

AN - SCOPUS:84942475184

VL - 195

SP - 3045

EP - 3057

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 7

ER -